![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ALFRESA PHARMA RELEASES HEMOTECT NS-PLUS C
ALFRESA PHARMA RELEASES HEMOTECT NS-PLUS C
Alfresa Holdings has announced its subsidiary Alfresa Pharma launched the Hemotect NS-Plus C, an automated immunochemical analyzer, and its proprietary reagent Nescoat HemoPlus for fecal occult blood tests. Used with the proprietary reagent, the analyzer, based on a discrete method, can detect fecal occult blood as well as tumor markers.
Japan Corporate News (http://japancorp.net/Article.Asp?Art_ID=9097)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct